Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
Status:
Completed
Trial end date:
2007-06-07
Target enrollment:
Participant gender:
Summary
The drugs GSK189075 and GW869682 result in increased caloric losses. This study is
investigating how if taken over 8 weeks that affects weight loss, food intake and the
composition of the body. The body composition (fat,water, lean mass) is determined using a
new investigational MR technology.